+1 617 937 2377 dmarino@cooley.com
David Marino is an associate in Cooley's corporate practice.
Download full bio
Akouos – $244 Million IPO
Battery Ventures Acquires 1WorldSync
Progyny – $150 Million IPO
Morphic Therapeutics - $104 Million IPO
Akero Therapeutics - $106 Million IPO
Venture Capital
Capital Markets
Emerging Companies
Mergers & Acquisitions
University of Michigan Law SchoolJD, cum laude, 2018
Ursinus CollegeBA, 2013
Massachusetts
+1 617 937 2377 office dmarino@cooley.com
500 Boylston Street14th FloorBoston, MA 02116-3736